Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

TrLink GMP Modified Nucleoside Triphosphates

TriLink has introduced the first GMP-grade Modified Nucleoside Triphosphates available, N1-Methylpseudouridine-5’-Triphosphate.

This modified nucleoside is chemically synthesized and ready to scale into your mRNA therapeutics production needs.

Premier Materials for mRNA Therapies
Backed by 25+ years of experience, TriLink’s industry-leading high-purity modified nucleoside triphosphates (NTPs) optimize and enhance mRNA performance to promote robust expression. Their extensive portfolio includes the most-requested modified NTPs, readily available and custom made to order.

Explore and learn about TriLink modified NTP

Download Brochure >



Request a Quote

Request Quote

Recent Posts

Developing Diagnostic Kits for Ovarian Cancer

In Australia, ovarian cancer is the deadliest reproductive cancer. The average five‑year survival rate sits at around 49%, compared with about 92% for breast cancer,…

Read full article

Merck FemtoQuest™

Gain your desired immunoassay sensitivity with the ultrasensitive FemtoQuest™ system Measure down to femtogram/mL levels Improved precision and robust data Perform dual-plex and single analyte…

Read full article

Vector VectaMount® Mounting Media for IHC

VectaMount Mounting Medium Products When applying a coverslip, selecting the appropriate mounting medium is essential to preserve the clarity, contrast, and stability of histochemical stains…

Read full article